Informed consent for polygenic risk score test in type 2 diabetes: A pilot study
Published online on August 17, 2025
Abstract
Research Ethics, Volume 22, Issue 2, Page 272-291, April 2026.
A polygenic risk score (PRS) is a genomic test that can reveal the risk of developing common diseases, such as type 2 diabetes. Before the testing, the participant must have sufficient understanding to give informed consent to participate in genomic ...
A polygenic risk score (PRS) is a genomic test that can reveal the risk of developing common diseases, such as type 2 diabetes. Before the testing, the participant must have sufficient understanding to give informed consent to participate in genomic ...